Real-world multicenter adherence to international guidelines in the management of upper tract urothelial carcinoma: insights from the ROBUUST 2.0 Registry

Key Points

• To assess adherence to EAU-AUA guidelines in managing upper tract urothelial carcinoma across multiple centers.
• Analysis of real-world data from the ROBUUST 2.0 Registry
• Focus on key indicators such as perioperative bladder instillation, lymph node dissection, and adjuvant chemotherapy
• Poor adherence to guidelines for perioperative bladder instillation of chemotherapy noted
• Inadequate performance of lymph node dissection identified
• Suboptimal administration of adjuvant chemotherapy for advanced cases observed